Stocks Explorer
Stocks
Sectors
Search
NeuroBo Pharmaceuticals, Inc.(NRBO) News
Profile
Chart
News
Analysis
Holders
NRBO price today
by TradingView
Date
Title
May 2
NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 2a Clinical Trial of DA-1241 for the Treatment of NASH
‹ Prev
Page
of 2
Next ›